Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.

Clinical Lymphoma, Myeloma & Leukemia
Yu WangLe-Ping Zhang

Abstract

Acute lymphoblastic leukemia (ALL) with t(1;19)/TCF3-PBX1 is a common genotype, and its prognosis has significantly improved owing to risk stratification and intensive treatment. This study aimed to determine the outcomes and prognostic factors of patients with TCF3-PBX1 treated with the modified Berlin-Frankfurt-Münster protocol. Between 2005 and 2017, a total of 1051 pediatric patients with ALL were enrolled. TCF3-PBX1 was detected by reverse-transcriptase PCR and/or cytogenetic analysis. Clinical characteristics and treatment outcomes were analyzed and compared in patients with TCF3-PBX1 and with other B-precursor ALL (B-ALL). TCF3-PBX1 was detected in 64 patients with ALL (6.1%), and all were of B-cell lineage. These patients were more likely to express the pre-B-ALL immunophenotype (P < .001), be in the National Cancer Institute high-risk group (P = .030), and exhibit more rapid disease clearance during induction therapy (P < .001) compared to patients with other B-ALL. However, the outcomes of this genotype were not better than those of other patients with intermediate risk. At a median (range) follow-up of 60.6 (0.8-184.5) months, the estimated 5-year overall survival was 85.2 ± 4.6% versus 88.2 ± 1.8% (P = .500) and 5-y...Continue Reading

References

Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M UckunN A Heerema
Aug 27, 1998·The New England Journal of Medicine·C H Pui, W E Evans
Nov 21, 2007·Haematologica·Leo KagerUNKNOWN Austrian BFM Study Group
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Feb 8, 2014·PloS One·Christofer DiakosJoseph L Wiemels
Mar 1, 2014·Cancer Medicine·Daisuke AsaiUNKNOWN Japan Association of Childhood Leukemia Study (JACLS) & Children's Cancer and Leukemia Study Group (CCLSG)
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiCharles G Mullighan
Apr 25, 2017·Pediatric Blood & Cancer·Hsiu-Ju YenDer-Cherng Liang
May 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naomi WinickWilliam L Carroll

❮ Previous
Next ❯

Citations

May 5, 2021·Clinical Lymphoma, Myeloma & Leukemia·Yu WangLe-Ping Zhang

❮ Previous
Next ❯